$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Iontophoretic delivery method 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61N-001/30
출원번호 US-0452136 (1989-12-14)
발명자 / 주소
  • Haak Ronald P. (San Jose CA) Gyory J. Richard (Los Altos CA) Yieh Jane (Millbrae CA)
출원인 / 주소
  • Alza Corporation (Palo Alto CA 02)
인용정보 피인용 횟수 : 71  인용 특허 : 0

초록

An improved method for delivering a drug or beneficial agent transdermally to humans by iontophoresis is provided. The method includes selecting and iontophoretically delivering the drug through a skin site which optimizes the transdermal delivery rate of the drug while minimizing inter-patient vari

대표청구항

A method of optimizing the transdermal flux of a beneficial agent from an iontophoretic agent delivery device through intact human skin and decreasing inter-patient skin resistance variability, comprising: selecting a skin site on intact back skin of the human; placing the iontophoretic delivery dev

이 특허를 인용한 특허 (71)

  1. Yanaki, Jamal S., Active electrode for transdermal medicament administration.
  2. Yanaki, Jamal S., Active transdermal medicament patch and circuit board for same.
  3. Zhang, Sheng; Ruiz, Rafael, Adhesive compositions for medical use: single additive as both the thickening agent and the accelerator.
  4. Archer Heidi K. ; Pettit Mitchell S., Analgesic and antiphlogistic compositions and therapeutic wrap for topical delivery.
  5. Bialer Meir,ILX ; Dagan Arie,ILX ; Sherbel Sussan,ILX, Anticonvulsant drugs and pharmaceutical compositions thereof.
  6. Naidu, Kamatham A., Ascorbyl esters for the treatment of cancer.
  7. Tan, Jun; Town, Terrence; Mullan, Michael, Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology.
  8. Katti, Kattesh V.; Gali, Hariprasad; Volkert, Wynn A., Biomolecule conjugation strategy using novel water-soluble phosphine-based chelating agents.
  9. Reyes, Joe, Composition to boost libido.
  10. Zhang, Sheng; Azevedo, Max; Ruiz, Sr., Rafael, Curing accelerator and method of making.
  11. Zhang, Sheng; Ruiz, Sr., Rafael; Azevedo, Max, Curing accelerator and method of making.
  12. Lee, Jeoung Soo; Webb, Charles Kenneth; Zimmerman, Robert; Ruiz, Sr., Rafael, Cyanoacrylate tissue adhesives.
  13. Lee, Jeoung Soo; Webb, Charles Kenneth; Zimmerman, Robert; Ruiz, Sr., Rafael; Zhang, Sheng, Cyanoacrylate tissue adhesives.
  14. Zhang, Sheng; Ruiz, Sr., Rafael; Azevedo, Max, Cyanoacrylate tissue adhesives with desirable permeability and tensile strength.
  15. Zhang, Sheng; Ruiz, Rafael, Cyanoacrylate-based liquid microbial sealant drape.
  16. Charles, Matthew, Formulations of human tissue kallikrein-1 for parenteral delivery and related methods.
  17. Tsibris John C. M. ; Porter Kathy B., Guinea pig model for leiomyomas.
  18. Charles, Matthew; Kolodka, Tadeusz; Williams, Mark, Human tissue kallikrein 1 glycosylation isoforms.
  19. Charles, Matthew; Kolodka, Tadeusz; Williams, Mark, Human tissue kallikrein 1 glycosylation isoforms.
  20. Katti Kattesh V. ; Karra Srinivasa Rao ; Berning Douglas E. ; Smith C. Jeffrey ; Volkert Wynn A. ; Ketring Alan R., Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same.
  21. Katti Kattesh V. ; Karra Srinivasa Rao ; Berning Douglas E. ; Smith C. Jeffrey ; Volkert Wynn A. ; Ketring Alan R., Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same.
  22. Hadden, John W., Immunotherapy for reversing immune suppression.
  23. Akiyama, Hidero; Nakayama, Mizuo; Matsumura, Takehiko; Matsumura, Akihiko, Iontophoresis device.
  24. Kanamura, Kiyoshi; Kosiba, Nobuharu; Nakayama, Mizuo; Matsumura, Takehiko; Akiyama, Hidero; Matsumura, Akihiko, Iontophoresis device.
  25. Kanamura, Kiyoshi; Matsumura, Takehiko; Nakayama, Mizuo; Akiyama, Hidero; Matsumura, Akihiko, Iontophoresis device.
  26. Sage Burton H. ; Bock Carl Randolph ; Green Philip G., Iontophoretic delivery of cell adhesion inhibitors.
  27. Sage Burton H. ; Bock Carl Randolph ; Green Philip G. ; Hussain Munir A. ; Repta Arnold J., Iontophoretic delivery of cell adhesion inhibitors.
  28. Zhang, Sheng; Ruiz, Sr., Rafael, Low dose gamma sterilization of liquid adhesives.
  29. Silvia S. Jurisson ; Thomas P. Quinn ; Michael F. Giblin, Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melanoma.
  30. Sakamoto, Fernanda Hidemi; Anderson, Richard Rox; Farinelli, William A.; Doukas, Apostolos G., Method and apparatus for optical inhibition of photodynamic therapy.
  31. Vardimon Lily,ILX, Method and composition for treating neuronal degeneration.
  32. Harpal S. Mangat ; Gerry Ballough ; Gary Brown, Method and composition for treatment of ischemic neuronal reperfusion injury.
  33. Charles B. Nemeroff ; Clinton D. Kilts, Method and devices for transdermal delivery of lithium.
  34. Norman ; Jr. James G., Method for decreasing severity of acute and chronic pancreatitis.
  35. Zuckerman,Kenneth S.; Liu,Richard Y., Method for the inhibition of function of STAT transcription factors.
  36. Zuckerman, Kenneth S.; Liu, Richard Y., Method for the modulation of function of transcription factors.
  37. Zuckerman,Kenneth S.; Liu,Richard Y., Method for the modulation of function of transcription factors.
  38. Shyam S. Mohapatra ; Hiroto Matsuse ; Aruna K. Behera ; Mukesh Kumar, Method of intranasal gene transfer for protection against respiratory infection.
  39. Zhang, Sheng; Ruiz, Rafael, Method of preparing adhesive compositions for medical use: single additive as both the thickening agent and the accelerator.
  40. Stephen Robert L. ; Stohrer Manfred,DEX ; Fontanella Umberto,ITX ; Griffith Donald P. ; Lugnani Franco,ITX ; Rossi Cino,ITX ; Eruzzi Silvio,ITX, Method of treating dysfunctional bladder syndromes by electromotive drug administration.
  41. Levy, Efrat, Methods and compositions relating to cystatin C.
  42. De Colle, Cyril; Pasricha, Pankaj, Methods for treating GI tract disorders.
  43. De Colle, Cyril; Pasricha, Pankaj, Methods for treating GI tract disorders.
  44. Feinstein,Elena; Mor,Orna, Methods of diagnosing bladder cancer.
  45. Jin, Xiaomei; Yu, Lei; Takahashi, Hirokazu; Tanaka, Yasunobu; Niitsu, Yoshiro; Feinstein, Elena; Avkin-Nachum, Sharon; Kalinski, Hagar; Mett, Igor; Erlich, Shai; Squiers, Elizabeth C.; Chen, Ning, Modulation of HSP47 expression.
  46. Jin, Xiaomei; Yu, Lei; Takahashi, Hirokazu; Tanaka, Yasunobu; Niitsu, Yoshiro; Feinstein, Elena; Avkin-Nachum, Sharon; Kalinski, Hagar; Mett, Igor; Erlich, Shai; Squiers, Elizabeth C; Chen, Ning, Modulation of HSP47 expression.
  47. Jin, Xiaomei; Yu, Lei; Takahashi, Hirokazu; Tanaka, Yasunobu; Niitsu, Yoshiro; Feinstein, Elena; Avkin-Nachum, Sharon; Kalinski, Hagar; Mett, Igor; Erlich, Shai; Squiers, Elizabeth C; Chen, Ning, Modulation of HSP47 expression.
  48. Paris, Daniel; Town, Terrence C.; Mullan, Michael J., Modulation of the phospholipase A2 pathway as a therapeutic.
  49. Jarvis, Gary A.; John, Constance M.; Leffler, Hakon, N-terminally truncated galectin-3 for use in treating cancer.
  50. Chopp, Michael; Zhang, Rui Lan, Nitric oxide donors for inducing neurogenesis.
  51. Chopp, Michael; Zhang, Rui Lan, Nitric oxide donors for inducing neurogenesis.
  52. Chopp,Michael; Zhang,Rui Lan, Nitric oxide donors for inducing neurogenesis.
  53. Feinstein, Elena; Adamsky, Svetlana; Avkin-Nachum, Sharon; Kalinski, Hagar; Mett, Igor, Oligonucleotide modulators of the toll-like receptor pathway.
  54. Feinstein, Elena; Adamsky, Svetlana; Avkin-Nachum, Sharon; Kalinski, Hagar; Mett, Igor, Oligonucleotide modulators of the toll-like receptor pathway.
  55. Richard Y. Liu ; Kenneth S. Zuckerman, Peptide antagonists of tumor necrosis factor alpha.
  56. Kraft, Edward R.; Kulp, Gabriela, Photokinetic delivery of biologically active substances using pulsed incoherent light.
  57. Kraft,Edward R.; Kulp,Gabriela, Photokinetic delivery of biologically active substances using pulsed incoherent light.
  58. De Colle, Cyril; Pasricha, Pankaj; Wustrow, David, Prodrugs of metopimazine.
  59. Zhang, Sheng; Ruiz, Rafael, Stable and sterile tissue adhesive composition with a controlled high viscosity.
  60. Zhang, Sheng; Ruiz, Sr., Rafael; Phelps, Shannon, Sterilized compositions of cyanoacrylate monomers and naphthoquinone 2,3-oxides.
  61. Zhang, Sheng; Ruiz, Sr., Rafael, Sterilized liquid compositions of cyanoacrylate monomer mixtures.
  62. Zhang, Sheng; Ruiz, Sr., Rafael, Sterilized liquid compositions of cyanoacrylate monomer mixtures.
  63. Carter, Darrick; Hoyt, Joshua K.; Thorne, James; Seitz, Forrest, Systems, devices, and methods for powering and/or controlling devices, for instance transdermal delivery devices.
  64. Sharpe Richard J. (Gloucester MA) Arndt Kenneth A. (Newton Centre MA) Galli Stephen J. (Winchester MA), Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis.
  65. Sharpe Richard J. (Cambridge MA) Arndt Kenneth A. (Newton Centre MA) Galli Stephen J. (Winchester MA), Topical application of buspirone for treatment of pathological conditions associated with immune responses.
  66. Richlin, David M.; Doherty, George R., Topical preparation and method for transdermal delivery and localization of therapeutic agents.
  67. Richlin, David M.; Doherty, George R., Topical preparation and method for transdermal delivery and localization of therapeutic agents.
  68. Hadden, John W.; Signorelli, Kathy; Egan, James, Vaccine immunotherapy.
  69. Hadden, John W., Vaccine immunotherapy for immune suppressed patients.
  70. Hadden,John W., Vaccine immunotherapy for immune suppressed patients.
  71. Perera, Ranjan, miR-211 expression and related pathways in human melanoma.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로